LILIANA BAROIU | Virology | Best Researcher Award

Published on by Molecular Biologist

Prof. Liliana Baroiu | Virology | Best Researcher Award

Professor Doctrate | Dunarea de jos University of Galati | Romania

Dr. Liliana Baroiu is a distinguished Romanian physician and academic specializing in infectious diseases. She serves as Head of the 2nd Infectious Diseases Clinic at the Clinical Hospital for Infectious Diseases “St. Cuvioasa Parascheva” in Galați and as Professor Habilitated at Dunărea de Jos University of Galați. Her expertise covers infectious pathology, epidemiology, and antiviral therapy, with extensive involvement in clinical trials and public health initiatives. She holds a Ph.D. in Medicine and advanced certifications in clinical research, health management, and ultrasonography. Throughout her career, Dr. Baroiu has progressed from resident to senior physician, assuming leadership roles in ethics, quality management, and clinical governance. Her research focuses on antimicrobial resistance, viral hepatitis, Clostridium difficile, and emerging infections, contributing to numerous international collaborations. With 44 scientific documents, 252 citations from 213 sources, and an h-index of 10, she has been recognized for her excellence in research, teaching, and institutional leadership, significantly advancing infectious disease medicine in Romania and beyond.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Baroiu, L., et al. “Impact of COVID-19 on Liver Function and Hepatitis Patients.” Medicina (MDPI). — Cited by 45 articles.

Baroiu, L., et al. “Clostridium difficile Infection in South-East Romania: Clinical and Epidemiological Insights.” Infectious Disease Reports. — Cited by 38 articles.

Baroiu, L., et al. “Clinical Features and Outcomes of COVID-19 Patients in Romania.” International Journal of Environmental Research and Public Health. — Cited by 120 articles.

Baroiu, L., et al. “Multidrug Resistance in Nosocomial Infections.” Healthcare (MDPI). — Cited by 60 articles.

Yu Chieh Su | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.